Neuro-Oncological Ventral Antigen 2 (NOVA2) Peptid
NOVA2
Reaktivität: Säugetier
Wirt: Synthetic
WB, BP, IHC
-
- Target Alle NOVA2 Produkte
- NOVA2 (Neuro-Oncological Ventral Antigen 2 (NOVA2))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Western Blotting (WB), Blocking Peptide (BP), Immunohistochemistry (IHC)
- Sequenz
- EPEQVHKAVS AIVQKVQEDP QSSSCLNISY ANVAGPVANS NPTGSPYASP
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of NOVA2 antibody,
Alternative Names: NOVA2 control peptide, NOVA2 antibody Blocking Peptide, Anti-NOVA2 Blocking Peptide, Neuro-Oncological Ventral Antigen 2 Blocking Peptide, NOVA2, NOVA-2, NOVA 2, NOVA-2 Blocking Peptide, NOVA 2 Blocking Peptide - Aufreinigung
- The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- NOVA2 (Neuro-Oncological Ventral Antigen 2 (NOVA2))
- Hintergrund
- NOVA2 may regulate RNA splicing or metabolism in a specific subset of developing neurons. It binds single strand RNA.
- Molekulargewicht
- 54 kDa
-
Sie sind hier:
